Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|14|3|340-342

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.3, 2014-02, pp. : 340-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

By Kataoka Yu  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1352-1360

Springer Publishing Company

Access to resources Recommend Favorite

Danusertib, an aurora kinase inhibitor

By Meulenbeld Hielke J   Mathijssen Ron HJ   Verweij Jaap   de Wit Ronald   de Jonge Maja JA  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Kinase Inhibitor Conjugates

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2891-2900

Bentham Science Publishers

Access to resources Recommend Favorite

The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 251-258

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Patented Src Kinase Inhibitor

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1821-1829

Bentham Science Publishers

Access to resources Recommend Favorite